問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Thoracic Medicine
下載
2010-03-01 - 2012-12-31
Condition/Disease
Test Drug
Participate Sites8Sites
Terminated8Sites
2020-07-01 - 2023-06-30
Participate Sites1Sites
Terminated1Sites
2020-08-01 - 2022-07-31
Obstructive Sleep Apnea of Adult, Mild Cognitive Impairment
18F-AV-45 (AV-45/Amyvid): (E)-4-(2-(6-(2-(2-(2-[18F] fluoroethoxyl) ethoxy)ethoxy)pyridine-3-yl)vinyl)-N-methylbenzenamine，10
Participate Sites4Sites
Recruiting4Sites
2008-10-01 - 2010-12-31
2008-09-01 - 2009-09-30
Participate Sites5Sites
Terminated5Sites
2010-01-01 - 2013-12-31
Participate Sites6Sites
Terminated6Sites
2008-10-01 - 2012-12-31
Participate Sites11Sites
Terminated11Sites
2009-10-01 - 2014-10-01
Participate Sites9Sites
Terminated9Sites
2015-06-02 - 2019-11-30
NSCLC
Ficlatuzumab (AV-299),
Terminated7Sites
未分科
2008-10-31 - 2012-10-31
全部
